跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NORPHEN TABLET - HSA Drug Approval Details
Approvals
/
HSA
/
NORPHEN TABLET
Approved
THERAPEUTIC
NORPHEN TABLET
ATLANTIC LABORATORIES CORPN LTD
🇸🇬 Health Sciences Authority
Approval Date
Dec 5, 2002
Approval ID
361efc96d734f5ef
Company
ATLANTIC LABORATORIES CORPN LTD
Type
Therapeutic
Approval Details
Approval Id
361efc96d734f5ef
Drug Name
NORPHEN TABLET
Product Name
NORPHEN TABLET
Approval Number
SIN12142P
Approval Date
2002-12-05
Registrant
ATLANTIC PHARMACEUTICAL (S) PTE LTD
Licence Holder
ATLANTIC PHARMACEUTICAL (S) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
M03BC51
Atc Item Name
orphenadrine, combinations
Pharma Manufacturer Name
atlantic pharmaceutical (s) pte ltd
Active Ingredients
ORPHENADRINE CITRATE
35 mg
PARACETAMOL
450 mg
ORPHENADRINE CITRATE
35 MG
PARACETAMOL
450 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 5, 2002
Approval ID
361efc96d734f5ef
Type
Therapeutic
Back to HSA Approvals